Curebound presents Ed Sheeran in Concert for Cures on Friday, October 20th at the Rady Shell! Tickets on sale now. Click here for more info.

[object Object],[object Object]

THE POWER OF
COLLABORATION

The best ideas happen when the right people work together.

Curebound
Curebound

CUREBOUND RESEARCH PROGRAM

COLLABORATIVE PARTNERS + INVESTMENT PILLARS

Collaboration is at the center of Curebound’s unique grantmaking platform. All Curebound grants demand collaboration among specialized teams from our research partner institutions, enabling the brightest minds from different scientific disciplines to work together to produce better options and outcomes for patients. Curebound'S institutional research partners include:

  • Moores Cancer Center at UC San Diego Health
  • Salk Institute
  • Sanford-Burnham Prebys
  • Rady Children’s Hospital
  • La Jolla Institute for Immunology
  • Scripps Research

Curebound funds promising, innovative oncology research for all types of cancer, adult and pediatric, in alignment with five scientific investment pillars:

  • Prevention and diagnostic tools
  • Novel approaches and new therapeutic platforms
  • Immunotherapies and personalized vaccines
  • Cancer equities
  • Pediatric cancers

CUREBOUND GRANTS

Curebound funds three levels of cancer research grants. For information on our annual grant cycle and application process, please contact our Grants Department via research@curebound.org

Discovery Grants

One-time seed grants of up to $250,000 for high-risk/high-reward, translational research. Ideas are innovative and in the early phases where smaller grants can make a big impact in advancing research.

Targeted Grants

Larger awards of $500,000 that aim to fund projects that are closer to clinical stages. Targeted Grants require interdisciplinary collaboration in order to ensure the project is geared toward translational application.

Cure Prizes

Innovative, multi-disciplinary projects that receive major funding of $1,000,000+ to be administered over multiple years. The Cure Prize challenge is to develop an innovation that will improve the standard of care for a typically deadly cancer with patient application in 3-5 years.

RESEARCH PORTFOLIO

Curebound raises and invests strategic funding in translational cancer research projects aimed at accelerating new discoveries to clinical application. The full index of our research portfolio is available below.

FILTER BY

Cancer Type

Institution

Pillar

Year

Type of Grant

Search

Curebound
Curebound

*Founders Bill & Amy Koman, Cure Prize Recipients Rebecca Rakow-Penner MD, PhD (UCSD), Michael McHale MD (UCSD), CEO Anne Marbarger*

*Not pictured: Anders Dale PhD (UCSD)*

CURE PRIZE

The Cure Prize is Curebound’s highest award for bold innovation in cancer research, recognizing Innovative, multi-disciplinary projects that receive major funding of $1,000,000+ to be administered over multiple years. The first Cure Prize challenge was to develop an innovation that will improve the standard of care for a typically deadly cancer with patient application in 3-5 years.

In June, 2022 Curebound awarded its first Cure Prize:

2023 Cure Prize: Screening for Ovarian Cancer with Advanced Diffusion MRI in Patients at High Risk for Ovarian Cancer
In Honor of the Koman Family

Scientists: Rebecca Rakow-Penner MD, PhD, Anders Dale, PhD, Michael McHale, MD (UC San Diego)

Ovarian cancer is the fifth-most deadly cancer in women in the United States with 60% of cases already metastasized at the time of diagnosis. Multiple screening programs have been attempted, but none so far have demonstrated survival benefit. This project, led by the brilliant team of doctors Rakow-Penner, Dale and McHale at UC San Diego, will develop a robust screening technique, based on advanced diffusion-weighted MRI, that can non-invasively image ovarian cancers. This will decrease the need for surgical removal of ovaries from at risk women while offering the promise of novel screening technique for early detection and treatment for all women.

“Our project, my passion, is to develop an innovative and advanced MRI protocol specifically tailored to detecting ovarian cancer in its earliest stages. By harnessing the power of cutting-edge technology, we aim to provide the information to at risk women so they can make informed decisions about their health and specifically about the very difficult decision they face with respect to prophylactic surgery. With the support of Curebound, we aim to significantly improve the outcomes for women facing this formidable challenge.”
- Rebecca Rakow-Penner, MD, PhD
UC San Diego Health

View the full Press Release about the 2023 Cure Prize

Read the 20223-23 Research Portfolio of Grants

Curebound

INSTITUTIONAL RESEARCH
PARTNERS

Curebound funds innovative, collaborative research between these six cancer research centers in San Diego.

undefined undefined
undefined undefined
undefined undefined
undefined undefined
undefined undefined
undefined undefined

RESOURCES

Curebound Discovery Grant - COMPRENDO Overview undefined

Curebound Discovery Grant - COMPRENDO Overview

Curebound Deck 2023 undefined

Curebound Deck 2023

2022-23 Research Portfolio undefined

2022-23 Research Portfolio

Curebound Giving Circles undefined

Curebound Giving Circles

2023 RFA undefined

2023 RFA

Curebound 2022 Video undefined

Curebound 2022 Video

Concert for Cures FAQ's undefined

Concert for Cures FAQ's

Curebound

EXPLORATION

Curebound
Curebound

ACCELERATION

Curebound
Curebound

COLLABORATION

Curebound
Curebound

CURES

HOW WOULD YOU LIKE TO REGISTER?

To join a team that participated in a previous Padres Pedal the Cause event or that has already been created for 2023, click ‘JOIN A TEAM’, and enter your team’s name.